Ayurvedic Proprietary Formulation for Cancer Care
Rejwin is a thoughtfully developed herbal and Ayurvedic formulation designed to provide comprehensive supportive care alongside conventional cancer treatment. It is formulated to support the body’s natural defence mechanisms, maintain physiological balance, and promote systemic wellness during the cancer-care journey.
Rejwin is an Ayurvedic Proprietary Formulation that, with its multi-dimensional approach, is intended to support healthy immune function, antioxidant defences, tissue integrity, and overall vitality. It may also help support the body in managing treatment-related stress and maintaining quality of life during chemotherapy and radiation therapy.
Rejwin is designed as an adjunctive Ayurvedic formulation to support the body’s natural response to processes associated with tumour growth, invasion and vascularisation. It should be used as part of an integrated care plan that may include medical treatment, balanced nutrition, physical activity, adequate rest, emotional support and regular clinical monitoring.
Rejwin is an Ayurvedic supportive-care formulation developed to complement conventional cancer treatment. It supports immune health, antioxidant defences, tissue integrity and overall vitality while helping the body maintain balance during the cancer-care journey. Designed for integrated use alongside appropriate medical care, nutrition, rest and clinical monitoring, Rejwin supports a patient-centred approach to well-being without replacing prescribed oncology treatment.
Cancer biology involves several overlapping mechanisms. A formulation that focuses only on antioxidant activity, only on immunity or only on inflammation may not adequately represent the complexity of the cancer-care environment.
Rejwin is based on a broader supportive framework:
Oxidative stress + inflammation + immune balance + nutrition + cellular wellness + vitality
These areas are interconnected. Oxidative stress may affect inflammatory signalling; inflammation may influence immune and metabolic function; poor nutrition may reduce resilience; and reduced vitality may affect recovery and quality of life. Rejwin's intended value lies in bringing these supportive dimensions together in one formulation, while maintaining appropriate scientific, regulatory and clinical boundaries.
Developed with high scientific rigour, Rejwin is formulated with a multi-targeted Phyto-complex designed to target key biological vulnerability pathways in tumour growth. Rejwin has been designed around the principle that cancer-associated biology is multifactorial. Its supportive concept is based on addressing several areas of physiological importance rather than claiming to act through one isolated pathway.
Rejwin is intended to offer supportive benefits within an integrated care and wellness plan.
Supports the body's natural antioxidant defence system and helps maintain normal cellular protection against oxidative stress.
Provides nutritional and herbal support for normal immune function and physiological resilience.
Supports a healthy inflammatory response and overall systemic balance.
Helps support normal cellular health, metabolic balance and protection from everyday physiological stress.
Supports general strength, vitality and day-to-day well-being.
Provides a multi-dimensional approach that can be incorporated into a broader plan involving medical treatment, nutrition, physical activity, sleep, psychological support, and regular clinical monitoring.
Suppresses unchecked cell division and induces targeted apoptosis in malignant cells.
Reduces pro-angiogenic factors (VEGF-A, MMP-2, MMP-9), helping to restrict the supply of blood and nutrients to tumour tissues.
Neutralizes reactive oxygen species (ROS) to protect healthy cells from oxidative stress and DNA damage.
Fits alongside standard oncology therapies (chemotherapy/radiation) to help manage side effects like fatigue, loss of appetite, and systemic weakness.
Pre-clinical studies demonstrate high selectivity for malignant cells without damaging healthy organ systems.
Certain traditional botanicals contain naturally occurring compounds that have been investigated in laboratory and preclinical studies for effects on cancer-cell proliferation, oxidative stress, inflammation, immune signalling, angiogenesis, and apoptosis.
Noni fruit contains anthraquinones such as damnacanthal, along with scopoletin, iridoids, coumarins, flavonoids, and polysaccharides. Research reviews note that noni preparations and damnacanthal have been studied for apoptosis-related and anti-proliferative activity in cancer models. Source
Soursop, also called graviola, contains annonaceous acetogenins, flavonoids, and polyphenols. Its acetogenins—particularly annonacin—have been widely studied for mitochondrial and apoptotic effects in cancer-cell models. Source
White water lily contains phenolic acids, flavonoids, and alkaloids, including gallic acid, ellagic acid, quercetin, kaempferol, apigenin, nupharine, and nymphaeine. These constituents have been studied individually for antioxidant, anti-proliferative, and apoptosis-related activity.
Palash, or Flame of the Forest, is a source of chalcone flavonoids, especially butein, along with butrin, isobutrin, butin, and coreopsin. Butein has been reviewed for broad preclinical biological activity, including antioxidant, anti-inflammatory, and anticancer properties. Source
Putranjiva contains flavonoids, tannins, phenolic acids, triterpenes, saponins, and glucosinolates. Its studied constituents include kaempferol, quercetin, rutin, tannic acid, ellagic acid, and gallic acid.
Simarouba, also known as Paradise Tree or Lakshmitaru, contains quassinoids including glaucarubinone, glaucarubin, glaucarubol, glaucarubolone, ailanthinone, and holacanthone.
Lodhra contains symplocosides, beta-carboline alkaloids, flavonoids, and triterpenes, including quercetin, oleanolic acid, and ursolic acid.
Turmeric contains curcuminoids, principally curcumin, demethoxycurcumin, and bisdemethoxycurcumin. Curcumin is among the most extensively studied plant-derived compounds for effects on inflammation, oxidative stress, and cancer-cell signalling.
Jeevanti contains flavonoids, phenolic acids, phytosterols, and triterpenes, including luteolin, apigenin, quercetin, kaempferol, rutin, ferulic acid, beta-sitosterol, stigmasterol, alpha-amyrin, and beta-amyrin.
Kanchanara contains flavonoids, anthocyanidin glycosides, and phytosterols, including kaempferol, quercetin, rutin, quercitrin, lupeol, stigmasterol, and beta-sitosterol.
The studies above were carried out on individual plant compounds in laboratory and preclinical models. They describe what has been researched about these botanicals, not proven effects of Rejwin in people. Rejwin is a supplement to, not a substitute for, treatment prescribed by your doctor.
Backed by a granted Indian Patent, "A Method and Composition for Preparation of Herbal Solution for Cancer Treatment".
Tested across 14 malignant cell lines and multiple In-vivo models.
Combines pro-apoptotic activity (restoring natural cell death in malignant cells) with anti-angiogenic action (inhibiting new blood vessel growth towards malignant tumours).
Selective toward malignant cells with minimal toxicity to healthy tissues, as demonstrated in toxicology testing.
Manufactured in perpetual AYUSH-licensed facilities License No. AUS-862, with GMP and ISO 9001:2015 quality certifications.
Produced under a strictly controlled farm-to-product manufacturing model.
Rejwin is designed to support several areas of wellness: including antioxidant defence, immune resilience, inflammation balance, cellular health, nutrition and vitality; rather than presenting a single-pathway concept.
The product is positioned as an adjunctive wellness formulation. It does not claim to replace oncology treatment, allowing the communication to remain responsible and patient-centred.
The formulation concept is aligned with contemporary understanding of cancer biology, including oxidative stress, inflammation, immune evasion, altered metabolism, cellular survival and the tumour microenvironment.
Rejwin considers the person beyond the tumour by focusing on general strength, nutritional support, resilience, and quality of life.
The product combines the traditional relevance of herbal support with the structured approach of ayurvedic product development, quality evaluation, standardization and responsible communication.
Rejwin can be considered as part of a broader care strategy involving the treating oncologist, dietitian, pharmacist, Ayurvedic physician and other qualified healthcare professionals.
Rejwin may be considered for adults seeking nutritional and herbal support during the cancer-care journey, subject to professional advice and individual suitability.
It may be relevant for:
Rejwin is an herbal and ayurvedic supportive-care product intended to support general wellness, antioxidant defence, immune function, nutritional status and vitality. It is not intended to diagnose, treat, cure or prevent cancer or any other disease. Rejwin is not a replacement for surgery, chemotherapy, radiotherapy, immunotherapy, targeted therapy, hormonal therapy or any treatment prescribed by a qualified healthcare professional.
Cancer care is a journey that requires medical expertise, nutritional attention, emotional support and informed personal care. Rejwin has been developed with a multi-target supportive philosophy to help address important aspects of overall wellness; including antioxidant protection, immune resilience, inflammation balance, cellular health, nutrition and vitality. With responsible use, professional guidance, and continued medical supervision, Rejwin may form part of an integrated supportive-care approach focused on helping individuals maintain strength and well-being throughout their cancer-care journey.